Search

Your search keyword '"Lema L"' showing total 334 results

Search Constraints

Start Over You searched for: Author "Lema L" Remove constraint Author: "Lema L"
334 results on '"Lema L"'

Search Results

12. Abordaje de un hematoma encapsulado a través de la técnica Roviralta

13. Serum cotinine cut-points for secondhand smoke exposure assessment in children under 5 years: A systemic review

15. 330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH

18. AB0342 OBSTETRIC AND THROMBOTIC ANTIPHOSPHOLIPID SYNDROME: ARE THEY DIFFERENT ENTITIES?

19. 22P HER2-low vs HER2-zero metastatic breast carcinoma: A clinical and genomic descriptive analysis

20. HASH(0x563d4406b2f8)

22. 57P Benefit of CDK4/6 inhibitors beyond PIK3CA mutations in metastatic breast cancer patients

23. 182TiP Effectiveness of niraparib plus aromatase inhibitors (AI) for germinal BRCA1/2-mutated (gBRCAm) or homologous recombination deficient (HRD), hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer (ABC). The LUZERN Strategy

24. HASH(0x563d44022ed0)

25. Tumor-infiltrating Lymphocytes Expression in Stage IIIc/IV of High-grade Serous Ovarian Cancer: Variation with Neoadjuvant Chemotherapy and Prognostic Value

29. Associations between physical fitness and adiposity among school-age children from Monteria, Colombia

30. Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value

31. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

33. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

36. [Development and use of a quality assessment scale specifically constructed for the assessment of studies that compare hemodialysis modalities]

39. Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients

Catalog

Books, media, physical & digital resources